thiazoles has been researched along with Diabetic Neuropathies in 30 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (20.00) | 18.7374 |
| 1990's | 12 (40.00) | 18.2507 |
| 2000's | 8 (26.67) | 29.6817 |
| 2010's | 3 (10.00) | 24.3611 |
| 2020's | 1 (3.33) | 2.80 |
| Authors | Studies |
|---|---|
| Ishii, Y; Kakefuda, R; Katsuda, Y; Maekawa, M; Ohta, T; Okuma, C; Sano, R; Sasase, T; Tadaki, H; Tomimoto, D; Yoshiuchi, H | 1 |
| Chen, Y; Hu, L; Huang, X; Lu, Y; Shen, X; Wang, J; Xu, X; Zhou, J; Zhu, X | 1 |
| Choi, YJ; Hong, JR; Keum, G; Nam, G | 1 |
| Abbasi, Z; Khaksari, M; Nazarnezhad, S; Rahmati, M; Salehi, M; Shayannia, A | 1 |
| Kimura, S; Kontani, H | 1 |
| Osawa, K; Ota, T | 1 |
| Chyun, DA; Johnson, BF; Law, G; Nesto, RW; Pfeifer, MA; Slater, WR; Vinik, AI; Wackers, FJ; Young, LH | 1 |
| Nakamura, J | 1 |
| Chappell, AS; D'Souza, DN; Iyengar, S; Pritchett, YL; Raskin, J; Smith, TR; Wang, F; Wernicke, JF | 1 |
| Cooper, ME; Forbes, JM; Sourris, KC | 1 |
| Hatanaka, I; Kikkawa, R; Kobayashi, N; Morimura, T; Shigeta, Y; Terashima, H; Tsuboshima, M; Yasuda, H | 1 |
| Hatanaka, I; Kikkawa, R; Kobayashi, N; Shigeta, Y; Yasuda, H | 1 |
| Ishikawa, H; Kobayashi, F; Matsui, T; Matsuura, A; Nakamura, Y | 1 |
| Krzan, M; Vodusek, DB; Vrtovec, M; Zgur, T | 1 |
| Vondrácková, D | 1 |
| Cerný, R; Egerová, Y; Krejcová, H; Vondrácková, D | 1 |
| Abe, N; Akaike, N; Aotsuka, T; Ashizawa, N; Fukushima, K; Matsuura, A; Ohbayashi, S; Sugiyama, Y; Yoshida, M | 1 |
| Akira, T; Naka, H | 1 |
| Akaike, N; Aotsuka, T; Ashizawa, N; Matsuura, A; Ohbayashi, S; Sugiyama, Y; Yoshida, M | 1 |
| Fukuzawa, M; Masuda, T; Muto, G; Muto, Y; Qiang, X; Sagara, M; Sakata, Y; Satoh, J; Takahashi, K; Toyota, T | 1 |
| Beaudet, LN; Dorsey, DA; Ido, Y; Plurad, SB; Schmidt, RE; Williamson, JR | 1 |
| Arezzo, JC | 1 |
| Chaya, S; Hamada, Y; Hotta, N; Ienaga, K; Kamiya, H; Kasuya, Y; Kato, K; Koh, N; Miwa, K; Mizubayashi, R; Nakamura, J; Nakashima, E; Nakayama, M; Naruse, K; Sakakibara, F; Yasuda, Y | 1 |
| Kakimoto, K; Shibata, T; Takeuchi, S; Wakitani, K; Yokota, S; Yonemori, F | 1 |
| Bíró, K; Jednákovits, A; Kukorelli, T; Kürthy, M; Mogyorósi, T; Nagy, K; Tálosi, L | 1 |
| Banga, JD; Hendriksen, PH; Oey, PL; van Dam, PS; Wieneke, GH | 1 |
| Hatanaka, I; Huitian, Z; Shigeta, Y; Sonobe, M; Terada, M; Yamashita, M; Yasuda, H | 1 |
| Kondo, M; Nakano, K; Nishioka, H; Terashima, H; Yoshida, T; Yoshioka, K | 1 |
| Akiguchi, I; Kuriya, N; Miyake, S; Mori, T; Nakanishi, T; Takahashi, A; Toyama, K; Ueda, Y; Yamaguchi, Y; Yokota, A | 1 |
| Fukasawa, H; Hotta, N; Iida, M; Kakuta, H; Kimura, M; Koh, N; Morimura, T; Sakamoto, N; Terashima, H | 1 |
4 review(s) available for thiazoles and Diabetic Neuropathies
| Article | Year |
|---|---|
[Development of therapeutic agents for diabetic neuropathies].
Topics: Aldehyde Reductase; Antioxidants; C-Peptide; Diabetic Neuropathies; Drug Design; Enzyme Inhibitors; Genetic Therapy; Glycation End Products, Advanced; Hedgehog Proteins; Humans; Indoles; Maleimides; Nerve Growth Factor; Oxidative Stress; Polymers; Protein Kinase C; Rhodanine; Thiadiazoles; Thiamine; Thiazoles; Thiazolidines; Trans-Activators; Vascular Endothelial Growth Factor A | 2005 |
Therapeutic interruption of advanced glycation in diabetic nephropathy: do all roads lead to Rome?
Topics: Carnosine; Diabetes Complications; Diabetic Neuropathies; Glycation End Products, Advanced; Humans; Reactive Oxygen Species; Thiazoles | 2008 |
[SG-210].
Topics: Aldehyde Reductase; Animals; Benzothiazoles; Diabetic Neuropathies; Diabetic Retinopathy; Enzyme Inhibitors; Erythrocytes; Humans; Hypoglycemic Agents; Sorbitol; Thiazines; Thiazoles | 1997 |
New developments in the diagnosis of diabetic neuropathy.
Topics: Aldehyde Reductase; Axons; Benzothiazoles; Biopsy; Controlled Clinical Trials as Topic; Diabetic Neuropathies; Diagnosis, Differential; Electrophysiology; Enzyme Inhibitors; Humans; Immunohistochemistry; Neural Conduction; Peripheral Nerves; Phthalazines; Skin; Thiazoles | 1999 |
5 trial(s) available for thiazoles and Diabetic Neuropathies
| Article | Year |
|---|---|
Cardiac abnormalities in diabetic patients with neuropathy: effects of aldose reductase inhibitor administration.
Topics: Aldehyde Reductase; Benzothiazoles; Cardiac Output; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Neuropathies; Double-Blind Method; Enzyme Inhibitors; Exercise Test; Female; Heart; Heart Conduction System; Heart Rate; Humans; Male; Middle Aged; Phthalazines; Placebos; Stroke Volume; Thiazoles; Ventricular Function, Left | 2004 |
An open-label 52-week clinical extension comparing duloxetine with routine care in patients with diabetic peripheral neuropathic pain.
Topics: Acetaminophen; Amitriptyline; Analgesics; Carbamazepine; Diabetes Complications; Diabetic Neuropathies; Diclofenac; Double-Blind Method; Duloxetine Hydrochloride; Female; Humans; Lipids; Male; Meloxicam; Middle Aged; Neuralgia; Pentoxifylline; Selective Serotonin Reuptake Inhibitors; Thiamine; Thiazines; Thiazoles; Thioctic Acid; Thiophenes; Time; Vitamin B 12 | 2007 |
Efficiency of the antihypoxic substance sabeluzole in patients with clinically and neurophysiologically evident diabetic polyneuropathy.
Topics: Adult; Aged; Autonomic Nervous System; Diabetic Neuropathies; Double-Blind Method; Female; Humans; Male; Middle Aged; Neurologic Examination; Peripheral Nerves; Piperidines; Thiazoles | 1993 |
[Treatment of polyneuropathy using sabeluzole].
Topics: Diabetic Neuropathies; Double-Blind Method; Female; Humans; Male; Middle Aged; Nervous System Diseases; Piperidines; Thiazoles | 1993 |
Antihypoxic treatment at an early stage of diabetic neuropathy: an electrophysiological study with sabeluzole.
Topics: Adult; Aged; Autonomic Nervous System Diseases; Cell Hypoxia; Diabetes Mellitus, Type 2; Diabetic Neuropathies; Double-Blind Method; Electromyography; Female; Follow-Up Studies; Humans; Male; Middle Aged; Nerve Degeneration; Neurologic Examination; Peripheral Nerves; Piperidines; Sensory Thresholds; Synaptic Transmission; Thiazoles | 1992 |
21 other study(ies) available for thiazoles and Diabetic Neuropathies
| Article | Year |
|---|---|
A Novel TNF-α Converting Enzyme (TACE) Selective Inhibitor JTP-96193 Prevents Insulin Resistance in KK-A
Topics: ADAM17 Protein; Adipose Tissue; Animals; Blood Glucose; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Neuropathies; Insulin Resistance; Male; Mice; Mice, Inbred C57BL; Mice, Inbred ICR; Rats; Rats, Inbred Lew; Thiazoles; Tumor Necrosis Factor-alpha | 2019 |
SP6616 as a Kv2.1 inhibitor efficiently ameliorates peripheral neuropathy in diabetic mice.
Topics: Animals; Apoptosis; Biomarkers; Calcium; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Disease Models, Animal; Ganglia, Spinal; Gene Expression Regulation; Immunohistochemistry; Male; Membrane Potential, Mitochondrial; Mice; Mitochondria; Neurites; Neurons; Protein Binding; Pyrimidines; Shab Potassium Channels; Signal Transduction; Thiazoles | 2020 |
Synthesis and diabetic neuropathic pain-alleviating effects of 2N-(pyrazol-3-yl)methylbenzo[d]isothiazole-1,1-dioxide derivatives.
Topics: Animals; Calcium Channel Blockers; Calcium Channels, T-Type; Diabetic Neuropathies; Disease Models, Animal; Half-Life; Humans; Inhibitory Concentration 50; Male; Microsomes, Liver; Neuralgia; Pyrazoles; Rats; Structure-Activity Relationship; Thiazoles | 2017 |
Nesfatin-1 protects PC12 cells against high glucose-induced cytotoxicity via inhibiting oxidative stress, autophagy and apoptosis.
Topics: Animals; Apoptosis; Autophagy; Cell Survival; Diabetic Neuropathies; Glucose; Membrane Potential, Mitochondrial; Necrosis; Neuroprotective Agents; Nucleobindins; Oxidative Stress; PC12 Cells; Rats; Reactive Oxygen Species; Tetrazolium Salts; Thiazoles | 2019 |
Demonstration of antiallodynic effects of the cyclooxygenase-2 inhibitor meloxicam on established diabetic neuropathic pain in mice.
Topics: Analgesics; Animals; Cyclooxygenase 2 Inhibitors; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Injections, Intraperitoneal; Injections, Spinal; Male; Meloxicam; Mice; Pain; Pain Measurement; Thiazines; Thiazoles | 2009 |
Marked improvement of glycaemic control with pioglitazone in a Type 2 diabetic patient associated with Charcot-Marie-Tooth disease.
Topics: Body Weight; Charcot-Marie-Tooth Disease; Diabetes Mellitus, Type 2; Diabetic Neuropathies; Humans; Hypoglycemic Agents; Insulin Resistance; Male; Middle Aged; Pioglitazone; Thiazoles; Thiazolidinediones; Treatment Outcome | 2003 |
Effect of a new aldose reductase inhibitor, (E)-3-carboxymethyl-5-[(2E)-methyl-3-phenylpropenylidene]rhodanine (ONO-2235) on peripheral nerve disorders in streptozotocin-diabetic rats.
Topics: Aldehyde Reductase; Animals; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Erythrocytes; Insulin; Male; Neural Conduction; Rats; Rats, Inbred Strains; Rhodanine; Sciatic Nerve; Sorbitol; Sugar Alcohol Dehydrogenases; Thiazoles; Thiazolidines | 1983 |
Prevention of peripheral nerve dysfunction by an aldose reductase inhibitor in streptozotocin-diabetic rats.
Topics: Aldehyde Reductase; Animals; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Male; Motor Neurons; Neural Conduction; Rats; Rats, Inbred Strains; Rhodanine; Sciatic Nerve; Sorbitol; Sugar Alcohol Dehydrogenases; Thiazoles; Thiazolidines | 1984 |
Pharmacological profiles of a novel aldose reductase inhibitor, SPR-210, and its effects on streptozotocin-induced diabetic rats.
Topics: Aldehyde Reductase; Animals; Benzothiazoles; Cattle; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Diabetic Retinopathy; Electroretinography; Erythrocytes; Humans; Kinetics; Male; Motor Neurons; Neural Conduction; Rats; Rats, Sprague-Dawley; Sorbitol; Swine; Thiazines; Thiazoles | 1994 |
[EMG findings in patients with diabetic polyneuropathy treated with sabeluzole].
Topics: Diabetes Mellitus, Type 2; Diabetic Neuropathies; Electromyography; Humans; Piperidines; Thiazoles | 1993 |
Effects of a novel potent aldose reductase inhibitor, GP-1447, on aldose reductase activity in vitro and on diabetic neuropathy and cataract formation in rats.
Topics: Aldehyde Reductase; Animals; Blood Glucose; Body Weight; Cataract; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Enzyme Inhibitors; Humans; Male; Phenylacetates; Rats; Rats, Sprague-Dawley; Sorbitol; Thiazoles | 1997 |
Amelioration of neurovascular deficits in diabetic rats by a novel aldose reductase inhibitor, GP-1447: minor contribution of nitric oxide.
Topics: Aldehyde Reductase; Animals; Blood Glucose; Body Weight; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Erythrocyte Deformability; Male; Motor Neurons; Neural Conduction; Nitric Oxide; Nitric Oxide Synthase; Nitroarginine; Phenylacetates; Rats; Rats, Sprague-Dawley; Sciatic Nerve; Sorbitol; Thiazoles | 1998 |
Inhibitory effect of troglitazone on diabetic neuropathy in streptozotocin-induced diabetic rats.
Topics: Animals; Antioxidants; Blood Glucose; Body Weight; Chromans; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Lipid Peroxidation; Lipid Peroxides; Male; Motor Neurons; Neural Conduction; Rats; Rats, Wistar; Thiazoles; Thiazolidinediones; Tibial Nerve; Troglitazone | 1998 |
Effect of sorbitol dehydrogenase inhibition on experimental diabetic autonomic neuropathy.
Topics: Animals; Autonomic Nervous System Diseases; Benzothiazoles; Diabetic Neuropathies; Drug Evaluation, Preclinical; Enzyme Inhibitors; Ganglia, Sympathetic; L-Iditol 2-Dehydrogenase; Male; Mesentery; Neuroaxonal Dystrophies; Phthalazines; Piperazines; Pyrimidines; Rats; Rats, Sprague-Dawley; Thiazoles | 1998 |
A protein kinase C-beta-selective inhibitor ameliorates neural dysfunction in streptozotocin-induced diabetic rats.
Topics: Aldehyde Reductase; Animals; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Drug Therapy, Combination; Enzyme Inhibitors; Fructose; Indoles; Isoenzymes; Male; Maleimides; Motor Neurons; Neural Conduction; Protein Kinase C; Protein Kinase C beta; Pyrimidinones; Rats; Rats, Wistar; Sciatic Nerve; Sorbitol; Thiazoles | 1999 |
Effects of peroxisome proliferator-activated receptor-alpha and -gamma agonist, JTT-501, on diabetic complications in Zucker diabetic fatty rats.
Topics: Absorptiometry, Photon; Animals; Body Weight; Bone Density; Bone Diseases, Metabolic; Cataract; Chromans; Diabetes Complications; Diabetes Mellitus; Diabetic Nephropathies; Diabetic Neuropathies; Eating; Hypoglycemic Agents; Isoxazoles; Male; Neural Conduction; Obesity; Pancreas; Rats; Rats, Zucker; Receptors, Cytoplasmic and Nuclear; Thiazoles; Thiazolidinediones; Time Factors; Transcription Factors; Troglitazone | 2000 |
Effect of BRX-220 against peripheral neuropathy and insulin resistance in diabetic rat models.
Topics: Animals; Diabetic Neuropathies; Guanidines; Hydroxylamines; Hypoglycemic Agents; Insulin Resistance; Male; Metformin; Pioglitazone; Rats; Rats, Wistar; Rats, Zucker; Streptozocin; Thiazoles; Thiazolidinediones | 2002 |
Effect of prostaglandin E1 analogue TFC 612 on diabetic neuropathy in streptozocin-induced diabetic rats. Comparison with aldose reductase inhibitor ONO 2235.
Topics: Adenosine Triphosphate; Aldehyde Reductase; Alprostadil; Animals; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Electrophysiology; Inositol; Lactates; Male; Myelin Sheath; Nerve Fibers; Phosphocreatine; Rats; Rats, Inbred Strains; Rhodanine; Sciatic Nerve; Sorbitol; Streptozocin; Sugar Alcohol Dehydrogenases; Thiazoles; Thiazolidines | 1989 |
Effect of aldose reductase inhibitor ONO 2235 on reduced sympathetic nervous system activity and peripheral nerve disorders in STZ-induced diabetic rats.
Topics: Aldehyde Reductase; alpha-Methyltyrosine; Animals; Autonomic Nervous System Diseases; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Erythrocytes; Female; Methyltyrosines; Neural Conduction; Norepinephrine; Peripheral Nervous System Diseases; Rats; Rats, Inbred Strains; Rhodanine; Sciatic Nerve; Sorbitol; Streptozocin; Sugar Alcohol Dehydrogenases; Sympathetic Nervous System; Thiazoles; Thiazolidines; Triiodothyronine | 1987 |
Effects of aldose reductase inhibitor on the peripheral nerve function during ischemia in diabetics.
Topics: Action Potentials; Adolescent; Adult; Aldehyde Reductase; Arm; Child; Diabetic Neuropathies; Female; Humans; Ischemia; Male; Middle Aged; Peripheral Nerves; Rhodanine; Sugar Alcohol Dehydrogenases; Thiazoles; Thiazolidines | 1987 |
Effects of a fructose-rich diet and the aldose reductase inhibitor, ONO-2235, on the development of diabetic neuropathy in streptozotocin-treated rats.
Topics: Aldehyde Reductase; Animals; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Dietary Carbohydrates; Erythrocytes; Fructose; Male; Motor Neurons; Neural Conduction; Rats; Retina; Rhodanine; Sciatic Nerve; Sorbitol; Sugar Alcohol Dehydrogenases; Thiazoles; Thiazolidines | 1985 |